Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.
COVID-19 vaccine tourism has swiftly evolved into a thriving global industry as people look to secure a quick vaccination fix.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
When Monash University announced world-first COVID-19 research in July, the crucial behind-the-scenes work of a group of PhD students went largely unnoticed.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
The delivery of a COVID-19 vaccine still needs to overcome some ethical hurdles.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Finding a way out of the COVID-19 crisis will firstly require more urgent and coordinated investment in medical innovation.
Critically ill patients from intensive care units are part of a global trial testing a suite of flu and pneumonia drugs in a bid to combat COVID-19.
How prepared are we to give up some personal freedoms, and how do we allocate scarce resources? These are just some of the tough questions we face.
Dummy text